TD Cowen raised the firm’s price target on Amgen (AMGN) to $336 from $293 and keeps an Outperform rating on the shares. The firm updated their model to account for the acquisition of HorizonTherapeutics (HZNP).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMGN:
